Please login to the form below

Not currently logged in
Email:
Password:

heart attack

This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.

BMS’ new JAK inhibitor enters regulatory pathways

BMS’ new JAK inhibitor enters regulatory pathways

s Olumiant and AbbVie’s Rinvoq, citing ‘an increased risk of serious heart-related events such as heart attack or stroke, cancer, blood clots and death’.

Latest news

More from news
Approximately 5 fully matching, plus 225 partially matching documents found.

Latest Intelligence

  • The evolution of marketing – the Amgen way The evolution of marketing – the Amgen way

    Yet, cardiovascular disease is still the leading cause of death in Europe, and 80% of premature cases of heart disease and stroke are preventable. ... predict which cardiovascular disease patients are at high risk of a second event, such as a heart attack

  • Changing direction: adapting to a rapidly-evolving environment Changing direction: adapting to a rapidly-evolving environment

    In the era of the algorithm, your doctor can now predict you’ll have a fatal heart attack five years before it hits you. ... If we’re going to exploit the brilliance of technology to change behaviours and transform health outcomes, marketing and

  • Insights from Cannes Lions Health Festival 2018 Insights from Cannes Lions Health Festival 2018

    sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.

  • Proving real-world value Proving real-world value

    Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.

  • Why health psychology is the answer to tackling adherence Why health psychology is the answer to tackling adherence

    Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...